Adagio Medical Holdings, Inc.

ADGM · NASDAQ

Adagio has pivotal VT data, FDA Breakthrough Device status, and a CE-Marked system, but no current revenue, a going-concern warning, and a cash runway that makes every regulatory milestone matter.

Follow Add to Watchlist Ask Question

NASDAQ ADGM Coverage Bootstrap Medical Devices Cardiac Electrophysiology Clinical Stage

Latest ReportMay 14, 2026Adagio Medical: the $12.9M cash clock behind a make-or-break VT filingView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->

Admin-only preview

Valuation is limited to admins for now.

The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.